Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[CPT-11 hepatic arterial infusion chemotherapy for metastatic liver tumor from gastric cancer]Takeshi Nagahama, Masayuki Ando, Michio MaruyamaGan to Kagaku Ryoho. Cancer & Chemotherapy|May 2, 2007
[Home enteral nutrition for gastrectomy patients to provide "seamless nutritional support"]Michio Maruyama, Takeshi Nagahama, Shouji MaruyamaGan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
[A case of pyloric or antral malignant stenosis treated with arterial infusion chemotherapy and palliative therapy--self-expandable metal stents through gastrostomy]Yutaka Tokairin, Takeshi Nagahama, Michio MaruyamaGan to Kagaku Ryoho. Cancer & Chemotherapy|January 11, 2007
[MTX-CDDP-5-FU double modulation intra aortic chemotherapy for advanced and metastatic gastric cancer--a comparison with an intra venous route]Michio Maruyama, Takeshi Nagahama, Shouji MaruyamaGan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Weekly docetaxel in combination with concomitant radiotherapy for esophageal cancer]Takeshi Nagahama, Masayuki Ando, Katsunori Ami, et al.Hepato-Gastroenterology|May 9, 2002
Endoscopic comparison of two cases: distal resection of reconstructed gastric tubeTatsuya Yoshida, Takeshi Nagahama, Michio Maruyama, et al.Neuropsychiatric Disease and Treatment|August 28, 2018
Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case seriesYasunari Yamaguchi, Sohei Kimoto, Takeshi Nagahama, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis]Michio Maruyama, Masakazu Ebuchi, Takeshi Nagahama, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 25, 2008
[The future of loco-regional treatment for advanced gastric cancer]Takeshi Nagahama, Masayuki Ando, Hideaki Ganno, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2008
[Progression of gastric cancer observed for three and a half years under S-1 administration]Hiroyuki Baba, Kantaro Suzuki, Yuka Sawada, et al.Pageof 6